Skip to content
Poland Pharma and Healthcare Sector Report
2024-2025.png.png-1
EMIS INSIGHTS presenTS

Poland Pharma and Healthcare Sector Report 2024-2025
LinkedIn_carousel_1080x1350-3
EMIS INSIGHTS presenTS

Food & Beverages CEE Sector Report 2024-2025
 
This report provides a complete and detailed analysis of the automotive sector for Poland. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

Poland's healthcare and pharmaceutical industry is making significant strides, despite facing substantial challenges. The ongoing war in Ukraine, which followed the COVID-19 pandemic, has placed consider able pressure on the Polish healthcare system. Nevertheless, strategic investments and modernisation efforts are fostering positive developments. The healthcare and pharmaceutical retail sector is characterised by intense competition, with companies expanding their digital presence and retail networks. Leading firms, such as Neuca and Lux Med, are heavily investing in research and development to introduce innovative products and enhance efficiency. Polpharma, a major Polish manufacturer, is focusing on R&D for generic and biosimilar medicines. Despite market competition and regulatory hurdles, Poland's pharma and healthcare sector is set for sustained growth, propelled by technological advancements and strategic initiatives.


About this report

This sample report provides a comprehensive sector overview, with access to:
  • Pharmaceutical production
  • Market value
  • Foreign trade
  • Healthcare expenditure and more


    EMIS_icons_Persona Brochures_05_Business_Research 
    Are you interested in the full version of the report & more insights into the pharma and healthcare sector, more data, and analysis from the world's fastest-growing markets?

    Sign up for free to an EMIS demo & Check the full report

 

EMIS_insights
ABOUT EMIS INSIGHTS
 

What sets 'EMIS Insights' reports apart and makes them trustworthy?

EMIS operates in and reports on countries where high reward goes hand-in-hand with high risk. We bring you time-sensitive, hard-to-get, relevant news, research and analytical data, peer comparisons and more for over 197 emerging markets. Our EMIS Insights Report suite constitutes just a proportion of our deep emerging markets information platform.

Our recent reports

raport_1a

India Pharma & Healthcare Sector 2023/24

India’s pharmaceuticals and healthcare sector is globally renowned. India has a reputation for being the “pharmacy of the world” thanks to its prodigious output of generic medicines and vaccines. 

Download report
raport_2a

Indonesia Banking Sector 2023/24

Indonesia's economic recovery gathered pace in 2022, despite dynamic external and domestic challenges. 

Download report
raport_3a

Colombia Consumer Goods & Retail Sector 2023/24

Many retail segments in Colombia have yet to recover fully from the impact of the COVID-19 crisis. One example is the sale of new cars.

Download report
EMIS DEMO

Ready to explore EMIS?

EMIS DEMO

Ready to explore EMIS?

Request a demo